2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine

C137H241F3N22O10S — CID 158680073

IUPAC2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine
SMILESCC(C)(C)N1CC(N)C2(CC2)C1.CC(C)(C)N1CC(N2CCNCC2)C1.CC(C)(C)N1CC(Oc2ccc(C(F)(F)F)cc2)C1.CC(C)(C)N1CC(Oc2cccnc2)C1.CC(C)(C)N1CC2C(C1)C2N=C(N)N.CC(C)(C)N1CC2CC1CN2.CC(C)(C)N1CCC(C(O)c2cccs2)CC1.CC(C)(C)N1CC[C@H](O)[C@H]1CO.CC(C)(C)Oc1cnc2ccoc2c1.CN1CCN(C2CCN(C(C)(C)C)C2)CC1.COC[C@@H]1CCCN1C(C)(C)C.COc1ccc(OC2CN(C(C)(C)C)C2)cc1
InChIInChI=1S/C14H18F3NO.C14H21NO2.C14H23NOS.C13H27N3.C12H18N2O.C11H23N3.C11H13NO2.C10H20N4.C10H20N2.C10H21NO.C9H18N2.C9H19NO2/c1-13(2,3)18-8-12(9-18)19-11-6-4-10(5-7-11)14(15,16)17;1-14(2,3)15-9-13(10-15)17-12-7-5-11(16-4)6-8-12;1-14(2,3)15-8-6-11(7-9-15)13(16)12-5-4-10-17-12;1-13(2,3)16-6-5-12(11-16)15-9-7-14(4)8-10-15;1-12(2,3)14-8-11(9-14)15-10-5-4-6-13-7-10;1-11(2,3)14-8-10(9-14)13-6-4-12-5-7-13;1-11(2,3)14-8-6-10-9(12-7-8)4-5-13-10;1-10(2,3)14-4-6-7(5-14)8(6)13-9(11)12;1-9(2,3)12-6-8(11)10(7-12)4-5-10;1-10(2,3)11-7-5-6-9(11)8-12-4;1-9(2,3)11-6-7-4-8(11)5-10-7;1-9(2,3)10-5-4-8(12)7(10)6-11/h4-7,12H,8-9H2,1-3H3;5-8,13H,9-10H2,1-4H3;4-5,10-11,13,16H,6-9H2,1-3H3;12H,5-11H2,1-4H3;4-7,11H,8-9H2,1-3H3;10,12H,4-9H2,1-3H3;4-7H,1-3H3;6-8H,4-5H2,1-3H3,(H4,11,12,13);8H,4-7,11H2,1-3H3;9H,5-8H2,1-4H3;7-8,10H,4-6H2,1-3H3;7-8,11-12H,4-6H2,1-3H3/t;;;;;;;;;9-;;7-,8+/m.........0.1/s1
InChIKeyIEZUNOUBMQHBPC-NAORXBCVSA-N
MW2445.64 g/mol
LogP19.98
Rot. Bonds16

About 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine

2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine (PubChem CID 158680073) has the molecular formula C137H241F3N22O10S and a molecular weight of 2445.64 g/mol. Its IUPAC name is 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine.

Molecular Properties

Compound Name2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine
PubChem CID158680073
Molecular FormulaC137H241F3N22O10S
Molecular Weight2445.64 g/mol
Exact Mass2443.87
IUPAC Name2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine
SMILESCC(C)(C)N1CC(N)C2(CC2)C1.CC(C)(C)N1CC(N2CCNCC2)C1.CC(C)(C)N1CC(Oc2ccc(C(F)(F)F)cc2)C1.CC(C)(C)N1CC(Oc2cccnc2)C1.CC(C)(C)N1CC2C(C1)C2N=C(N)N.CC(C)(C)N1CC2CC1CN2.CC(C)(C)N1CCC(C(O)c2cccs2)CC1.CC(C)(C)N1CC[C@H](O)[C@H]1CO.CC(C)(C)Oc1cnc2ccoc2c1.CN1CCN(C2CCN(C(C)(C)C)C2)CC1.COC[C@@H]1CCCN1C(C)(C)C.COc1ccc(OC2CN(C(C)(C)C)C2)cc1
InChIInChI=1S/C14H18F3NO.C14H21NO2.C14H23NOS.C13H27N3.C12H18N2O.C11H23N3.C11H13NO2.C10H20N4.C10H20N2.C10H21NO.C9H18N2.C9H19NO2/c1-13(2,3)18-8-12(9-18)19-11-6-4-10(5-7-11)14(15,16)17;1-14(2,3)15-9-13(10-15)17-12-7-5-11(16-4)6-8-12;1-14(2,3)15-8-6-11(7-9-15)13(16)12-5-4-10-17-12;1-13(2,3)16-6-5-12(11-16)15-9-7-14(4)8-10-15;1-12(2,3)14-8-11(9-14)15-10-5-4-6-13-7-10;1-11(2,3)14-8-10(9-14)13-6-4-12-5-7-13;1-11(2,3)14-8-6-10-9(12-7-8)4-5-13-10;1-10(2,3)14-4-6-7(5-14)8(6)13-9(11)12;1-9(2,3)12-6-8(11)10(7-12)4-5-10;1-10(2,3)11-7-5-6-9(11)8-12-4;1-9(2,3)11-6-7-4-8(11)5-10-7;1-9(2,3)10-5-4-8(12)7(10)6-11/h4-7,12H,8-9H2,1-3H3;5-8,13H,9-10H2,1-4H3;4-5,10-11,13,16H,6-9H2,1-3H3;12H,5-11H2,1-4H3;4-7,11H,8-9H2,1-3H3;10,12H,4-9H2,1-3H3;4-7H,1-3H3;6-8H,4-5H2,1-3H3,(H4,11,12,13);8H,4-7,11H2,1-3H3;9H,5-8H2,1-4H3;7-8,10H,4-6H2,1-3H3;7-8,11-12H,4-6H2,1-3H3/t;;;;;;;;;9-;;7-,8+/m.........0.1/s1
InChIKeyIEZUNOUBMQHBPC-NAORXBCVSA-N
XLogP19.98
TPSA314.83 Ų
H-Bond Donors8
H-Bond Acceptors31
Rotatable Bonds16
Heavy Atoms173
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002445.64
LogP ≤ 519.98
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;1-(1-tert-butylazetidin-3-yl)ethanone;3-(1-tert-butylazetidin-3-yl)oxypyridine;tert-butyl N-(1-tert-butyl-3-methylazetidin-3-yl)carbamate;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-ethylpyrrolidin-3-ol;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;1-tert-butyl-3-methylazetidin-3-amine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;methane;1-methyl-5-[(2-methylpropan-2-yl)oxy]pyrrolo[2,3-b]pyridine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine
CID 158127081
CID 161605226
CID 161605226
3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-amine;N-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)-3,3-dimethylbutanamide;2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;4-(1-tert-butylazetidin-3-yl)morpholine;3-(1-tert-butylazetidin-3-yl)oxypyridine;tert-butyl N-(1-tert-butyl-3-methylazetidin-3-yl)carbamate;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-ethylpyrrolidin-3-ol;1-tert-butyl-3-methylazetidin-3-amine;(1-tert-butyl-3-methylazetidin-3-yl)methanamine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-methyl-5-[(2-methylpropan-2-yl)oxy]pyrrolo[2,3-b]pyridine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine;6-[(2-methylpropan-2-yl)oxy]quinoxaline
CID 161611137

Frequently Asked Questions

What is the IUPAC name of 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine?
The IUPAC name of 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine (CID 158680073) is 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine.
What is the SMILES notation for 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine?
The canonical SMILES for 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine is CC(C)(C)N1CC(N)C2(CC2)C1.CC(C)(C)N1CC(N2CCNCC2)C1.CC(C)(C)N1CC(Oc2ccc(C(F)(F)F)cc2)C1.CC(C)(C)N1CC(Oc2cccnc2)C1.CC(C)(C)N1CC2C(C1)C2N=C(N)N.CC(C)(C)N1CC2CC1CN2.CC(C)(C)N1CCC(C(O)c2cccs2)CC1.CC(C)(C)N1CC[C@H](O)[C@H]1CO.CC(C)(C)Oc1cnc2ccoc2c1.CN1CCN(C2CCN(C(C)(C)C)C2)CC1.COC[C@@H]1CCCN1C(C)(C)C.COc1ccc(OC2CN(C(C)(C)C)C2)cc1.
What is the InChIKey of 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine?
The InChIKey is IEZUNOUBMQHBPC-NAORXBCVSA-N. The full InChI is InChI=1S/C14H18F3NO.C14H21NO2.C14H23NOS.C13H27N3.C12H18N2O.C11H23N3.C11H13NO2.C10H20N4.C10H20N2.C10H21NO.C9H18N2.C9H19NO2/c1-13(2,3)18-8-12(9-18)19-11-6-4-10(5-7-11)14(15,16)17;1-14(2,3)15-9-13(10-15)17-12-7-5-11(16-4)6-8-12;1-14(2,3)15-8-6-11(7-9-15)13(16)12-5-4-10-17-12;1-13(2,3)16-6-5-12(11-16)15-9-7-14(4)8-10-15;1-12(2,3)14-8-11(9-14)15-10-5-4-6-13-7-10;1-11(2,3)14-8-10(9-14)13-6-4-12-5-7-13;1-11(2,3)14-8-6-10-9(12-7-8)4-5-13-10;1-10(2,3)14-4-6-7(5-14)8(6)13-9(11)12;1-9(2,3)12-6-8(11)10(7-12)4-5-10;1-10(2,3)11-7-5-6-9(11)8-12-4;1-9(2,3)11-6-7-4-8(11)5-10-7;1-9(2,3)10-5-4-8(12)7(10)6-11/h4-7,12H,8-9H2,1-3H3;5-8,13H,9-10H2,1-4H3;4-5,10-11,13,16H,6-9H2,1-3H3;12H,5-11H2,1-4H3;4-7,11H,8-9H2,1-3H3;10,12H,4-9H2,1-3H3;4-7H,1-3H3;6-8H,4-5H2,1-3H3,(H4,11,12,13);8H,4-7,11H2,1-3H3;9H,5-8H2,1-4H3;7-8,10H,4-6H2,1-3H3;7-8,11-12H,4-6H2,1-3H3/t;;;;;;;;;9-;;7-,8+/m.........0.1/s1.
What are the key properties of 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine?
2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine has a molecular weight of 2445.64 g/mol, XLogP of 19.98, 16 rotatable bonds, 8 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(3-tert-butyl-3-azabicyclo[3.1.0]hexan-6-yl)guanidine;5-tert-butyl-5-azaspiro[2.4]heptan-7-amine;3-(1-tert-butylazetidin-3-yl)oxypyridine;1-(1-tert-butylazetidin-3-yl)piperazine;2-tert-butyl-2,5-diazabicyclo[2.2.1]heptane;(2R,3S)-1-tert-butyl-2-(hydroxymethyl)pyrrolidin-3-ol;(2S)-1-tert-butyl-2-(methoxymethyl)pyrrolidine;1-tert-butyl-3-(4-methoxyphenoxy)azetidine;(1-tert-butylpiperidin-4-yl)-thiophen-2-ylmethanol;1-(1-tert-butylpyrrolidin-3-yl)-4-methylpiperazine;1-tert-butyl-3-[4-(trifluoromethyl)phenoxy]azetidine;6-[(2-methylpropan-2-yl)oxy]furo[3,2-b]pyridine is sourced from PubChem (CID 158680073), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).